Zobrazeno 1 - 10
of 186
pro vyhledávání: '"Kumazawa Joichi"'
Autor:
Kumazawa, Joichi, Yagisawa, Morimasa
Publikováno v:
In Journal of Infection and Chemotherapy 2002 8(2):125-133
Autor:
KOTAKE, Toshihiko, USAMI, Michiyuki, ISAKA, Shigeo, SHIMAZAKI, Jun, OISHI, Kenji, YOSHIDA, Osamu, OZONO, Sei-ichiro, OKAJIMA, Eigoro, KANETAKE, Hiroshi, SAITOH, Yutaka, TSUKAGOSHI, Shigeru, AKAZA, Hideyuki, KOISO, Kenkichi, KAMEYAMA, Shuji, HONMA, Yukio, ASO, Yoshio, NAKANO, Etsuji, OKUYAMA, Akihiko, NAITO, Seiji, KUMAZAWA, Joichi, NIITANI, Hisanobu, TAGUCHI, Tetsuo
Publikováno v:
泌尿器科紀要. 42(2):143-153
1)登録症例は16例で, 全例が適格例であった. 2)副作用は16例中8例に認められたが, 軽度で, 臨床上特に問題はなかった.乳房圧痛, 乳房腫脹等の副作用が50mg群で1例, 80mg群で3例及び100mg群で2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::2202c5e66781ec0bac003a8afda04c68
http://hdl.handle.net/2433/115668
http://hdl.handle.net/2433/115668
Autor:
KOTAKE, Toshihiko, USAMI, Michiyuki, ISAKA, Shigeo, SHIMAZAKI, Jun, NAKANO, Etsuji, OKUYAMA, Akihiko, OKAJIMA, Eigoro, KANETAKE, Hiroshi, SAITOH, Yutaka, KUMAMOTO, Yoshiaki, ORIKASA, Sei-ichi, SAKATA, Yasunosuke, HOSAKA, Masahiko, KAWAI, Tsuneo, TAZAKI, Hiroshi, KOHRI, Kenjiro, OHSHIMA, Shin-ichi, KATAYAMA, Takashi, ISURUGI, Koichiro, TAKAHA, Minato, WATANABE, Hiroki, KAMIDONO, Sadao, AKAZA, Hideyuki, KOISO, Kenkichi, HONMA, Yukio, ASO, Yoshio, OISHI, Kenji, YOSHIDA, Osamu, NAITOH, Seiji, KUMAZAWA, Joichi, KOYANAGI, Tomohiko, YACHIKU, Sunao, SHIRAIWA, Yasuo, YAMANAKA, Hidetoshi, KOSHIBA, Ken, OKADA, Kiyoki, KAWABE, Kazuki, OBATA, Koji, OHKAWA, Mitsuo, OKADA, Ken-ichiro, KURITA, Takashi, KISHIMOTO, Taketoshi, MATSUMURA, Yosuke, OHMORI, Hiroyuki, USUI, Tsuguru, MIYAGAWA, Ikuo, KAGAWA, Susumu, SACHO, Toshiaki, KAIHARA, Shigekoto, TAGUCHI, Tetsuo, TANAKA, Hiromiki, TAKEUCHI, Masahumi, OHI, Yoshitada, NODA, Shinshi, NIITANI, Hisanobu, TSUKAGOSHI, Shigeru
Publikováno v:
泌尿器科紀要. 42(2):155-168
ビカルタミド1日1回50mg群, 80mg及び100mgを12週間投与する3群比較の無作為化非盲検試験を実施した. 1)登録症例は124例で, 適格例は122例であった. 2)総合効果における奏効率は50mg群, 80mg群及び
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::ac6427de2fa21f681be23ed7371ef2ed
http://hdl.handle.net/2433/115667
http://hdl.handle.net/2433/115667
Autor:
Kumamoto, Yoshiaki, Tsukamoto, Taiji, Sato, Yoshikazu, Aoki, Masaharu, Umehara, Tsugio, Kubo, Takashi, Aoki, Hikaru, Matsuzaka, Junichi, Koiso, Kenkichi, Akaza, Hideyuki, Takeshima, Hitoshi, Kondo, Fukuji, Shimazaki, Jun, Akimoto, Susumu, Aso, Yoshio, Honma, Yukio, Sasaki, Yukihiro, Okada, Kiyoki, Nogaki, Joji, Yoshida, Hideki, Saito, Toyohiko, Watanabe, Masanobu, Shirai, Masafumi, Ishii, Nobuhisa, Osada, Takao, Yajima, Michitaka, Baba, Katsuyuki, Minagawa, Nobuhiko, Yoshida, Osamu, Arai, Yoichi, Komatsu, Yosuke, Matsuda, Tadashi, Mikami, Osamu, Ohara, Takashi, Isurugi, Koichiro, Hasegawa, Fumiaki, Araki, Tohru, Fujimoto, Hiroshi, Yuasa, Makoto, Kawanishi, Yasuo, Kumazawa, Joichi, Yamashita, Hiroshi, Takahashi, Koichi, Hara, Sanshin, Yamaguchi, Akito, Takei, Mineo, Nakashima, Mitsuyoshi
Publikováno v:
泌尿器科紀要. 40(8):745-759
前立腺肥大症患者を対象としてTZP-4238 (TZP群)の性的機能に対する影響および自覚的排尿障害に対する有効性, 安全性, 有用性を酢酸クロルマジノン(CMA群)を対照薬にして, 二重盲検法により
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::0979ccc935149ce368be91f25025e173
http://hdl.handle.net/2433/115321
http://hdl.handle.net/2433/115321
Autor:
Aso, Yoshio, Akaza, Hideyuki, Kameyama, Syuji, Kumamoto, Yoshiaki, Origasa, Seiichi, Sato, Hitoshi, Koiso, Kenkichi, Tazaki, Hiroshi, Kishimoto, Takashi, Kawachi, Yoshio, Iwata, Shinji, Hosaka, Masahiko, Nagayama, Tadao, Kawada, Yukimichi, Okajima, Eigoro, Sonoda, Takao, Ohmori, Hiroyuki, Matsumura, Yosuke, Koyanagi, Tomohiko, Funyu, Tomihisa, Yamanaka, Hidetoshi, Shiraiwa, Yasuo, Kawai, Tsuneo, Oshima, Hiroyuki, Kitagawa, Ryuichi, Takasu, Hidehiko, Machida, Toyohei, Shimazaki, Jun, Fuse, Hideki, Isaka, Shigeo, Okada, Kenichiro, Miyake, Koji, Yoshida, Osamu, Kotake, Toshihiko, Nanba, Katsuichi, Miyagawa, Ikuo, Josen, Taiichiro, Saito, Yutaka, Usui, Tsuguru, Kumazawa, Joichi, Ooi, Yoshitada
Publikováno v:
泌尿器科紀要. 39(4):391-403
1)内分泌療法未治療の前立腺癌症例に対し, 375mg/日の用量で単独療法として使用しえる。この際, testosterone産生阻害療法に比し, 「生活の質」が保たれる。2)内分泌療法再燃例に対しても,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::12ea39200ae487c1eb4e3f3dd0df15ea
http://hdl.handle.net/2433/117812
http://hdl.handle.net/2433/117812
Autor:
Matsumoto, Tetsuro, Haraoka, Masashi, Mizunoe, Yoshimitsu, Kubo, Shuta, Takahashi, Koichi, Tanaka, Masatoshi, Ogata, Nobuo, Kumazawa, Joichi
Publikováno v:
Acta medica et biologica. 40:23-29
The effects on renal scarring of bacterial pili and superoxide released by polymorphonuclear leukocytes (PMN) were examined using a rat experimental pyelonephritis model. Bacteria which possessed mannose-sensitive (MS) pili were found to promote rena
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::08c457fefcee09315fb8ac5ba633c641
https://niigata-u.repo.nii.ac.jp/records/6542
https://niigata-u.repo.nii.ac.jp/records/6542
Autor:
Naide, Yorio, Kumamoto, Yoshiaki, Hirose, Takaoki, Tsuchida, Seigi, Orikasa, Seiichi, Aso, Yoshiro, Oshi, Masaya, Machida, Toyohei, Suzuki, Keizo, Kawada, Yukimichi, Ban, Yoshihito, Okada, Kenichiro, Kamidono, Sadao, Arakawa, Soichi, Oomori, Hiroyuki, Kumon, Hiromi, Nihira, Hiromi, Kagawa, Susumu, Kumazawa, Joichi, Matsumoto, Tetsuro, Eto, Kosaku, Ohi, Yoshitada, Ueno, Kazue, Ogawa, Nobuya
Publikováno v:
泌尿器科紀要. 37(4):447-464
CPRは1回0.5 gまたは1.0 gを, CAZは1回1.0 gを1日2回, 点滴静注により5日間連続投与し, 臨床効果はUTI薬効評価基準により評価した.総投与症例530例中効果判定が可能であった症例はCPR 1日1 g投与
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::54d45f34aa0fb2631434f6b89ea57b6e
http://hdl.handle.net/2433/117148
http://hdl.handle.net/2433/117148
Autor:
Aso, Yoshio, Kameyama, Shuji, Ohmori, Hiroyuki, Ohashi, Teruhisa, Akimoto, Masao, Hosaka, Masahiko, Isurugi, Koichiro, Kamidono, Sadao, Kawabe, Kazuki, Kitagawa, Ryuichi, Kotake, Toshihiko, Usami, Michiyuki, Kumamoto, Yoshiaki, Niijima, Tadao, Murahashi, Isao, Koiso, Kenkichi, Akaza, Hideyuki, Fujita, Kimio, Ishii, Yasunori, Kagawa, Susumu, Katayama, Takashi, Kinoshita, Kenji, Koshiba, Ken, Koyanagi, Tomohiko, Kumazawa, Joichi, Ueda, Toyofumi, Nagakubo, Ichirou, Ohi, Yoshitada, Okamoto, Shigehiro, Oshima, Hiroyuki, Simazaki, Jun, Toma, Hiroshi, Watanabe, Hiroki, Kaihara, Shigekoto, Yokoyama, Masao, Okada, Kiyoki, Orikasa, Seiichi, Saito, Yutaka, Tazaki, Hiroshi, Usui, Tsuguru, Yamanaka, Hidetoshi, Yoshida, Osamu, Ohashi, Yasuo
Publikováno v:
泌尿器科紀要. 37(3):305-320
TAP-144-SRの前立腺癌に対する比較対照試験をリン酸ジエチルスチルベストロールを対照薬として行った.有効性では, 前立腺癌の判定基準の適格例で, TAP群54.5%(36/66), 対照群47.1%(32/68)のPR例が
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::3066bdbb98c1fb421e70376802dc05b8
http://hdl.handle.net/2433/117126
http://hdl.handle.net/2433/117126
Publikováno v:
Toxicology letters. 66(3)
Male Sprague-Dawley rats were intravenously injected with 6.5 mg/kg of cisplatin combined with a subcutaneous methylprednisolone (MP) injection to study the prophylactic effects of steroid hormone on cisplatin-induced nephrotoxicity. In Expt. 1, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7116907527554e45bb9d33d2841cb2ae
https://pubmed.ncbi.nlm.nih.gov/8475508
https://pubmed.ncbi.nlm.nih.gov/8475508
Publikováno v:
Journal of Surgical Oncology; Jun2001, Vol. 77 Issue 2, p123-131, 9p